Walden Biosciences
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $51M
Investors
- 2
About Walden Biosciences
Walden Biosciences, Inc.Founded in 2020, Walden Biosciences, Inc. is focused on creating therapies that target chronic kidney disease.Walden Biosciences specializes in the development of disease-modifying therapies for kidney diseases. Their primary products include CKD WAL0921 and CKD WAL0623, aimed at patients with chronic kidney disease, focusing on altering disease progression and enhancing patient quality of life.Walden Biosciences generates revenue through partnerships and collaborations with healthcare organizations and research institutions for the commercialization of its proprietary therapies. Their business model includes B2B agreements with hospitals and clinics, ensuring that products like WAL0921 and WAL0623 are accessible to patients. They are also looking to expand into new markets, specifically targeting Europe and North America by 2023.
Who invested in Walden Biosciences
2 investors across 1 round
See all investors in Walden Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 6, 2020
Amount
$51M
Investors
Questions about Walden Biosciences
Who invested in Walden Biosciences?
Walden Biosciences has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Walden Biosciences raised?
Walden Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Walden Biosciences last raise money?
Walden Biosciences's most recent round on record is a Series A, in Oct 2020.
What does Walden Biosciences do?
Walden Biosciences is a biotechnology company.
Where is Walden Biosciences headquartered?
Walden Biosciences is headquartered in Cambridge, US.
Which VCs invest in companies like Walden Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Walden Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Walden Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.